Answers are grounded in this paper and cite their sources.
This work reports the structural phase transition and lead-free properties of Rb3Bi2Br9–xIx halides, suggesting their potential for optoelectronic applications.
Rubidium-based halide perovskites Rb3Bi2Br9–xIx (x = 0, 3) represent a lead-free, low-dimensional alternative within the A3B2X9 family, offering promising optoelectronic properties. This work reports the successful synthesis of Rb3Bi2Br9 and Rb3Bi2Br6I3 via mechanochemical ball milling, yielding highly crystalline products. Structural characterization of Rb3Bi2Br9 halide, using synchrotron X-ray and neutron powder diffraction across a broad temperature range (295–656 K), revealed a reversible phase transition from a low-symmetry monoclinic (space group: P21/c) to a high-symmetry trigonal (space group: P3̅̅m1) phase at ∼450 K (both with a 2D dimensionality, concerning the connection of [BiBr6] octahedra). Thermal expansion coefficients, derived from unit-cell evolution, showed discontinuity across the structural phase transition. Symmetry-adapted distortion mode analysis identified octahedral tilting and rigid [BiBr6] framework rotations as the primary contributors to the monoclinic distortion, with minor and moderate contributions from stretching, bending, and Rb atoms translations. Optical characterization at room conditions (monoclinic phase) unveiled bandgaps of ∼2.70 and ∼2.21 eV for Rb3Bi2Br9 and Rb3Bi2Br6I3, respectively. Density functional theory (DFT) calculations corroborated the direct bandgap nature and electronic structure, highlighting the dominant Br and Bi orbital contributions. These results demonstrate the structural richness and optical tunability of Rb3Bi2Br9–xIx, establishing them as robust candidates for stable, lead-free optoelectronic applications.
No takes yet. Share an insight, caveat, or question.
Chakroun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: